Clinical burden and management of assisted reproduction in thrombophilia
| I. Clinical burden of oocyte transfer |
| Thrombosis risk49-51 |
| Hyperstimulation syndrome (OHSS)49-51 |
| II. Current approach to anticoagulation for ART |
| Agent: low molecular weight heparin53 |
| Length: for 3 mo post-DVT; for 3 mo post-OHSS symptoms53 |
| Anticoagulation per ASH guidelines in pregnancy53 |
| I. Clinical burden of oocyte transfer |
| Thrombosis risk49-51 |
| Hyperstimulation syndrome (OHSS)49-51 |
| II. Current approach to anticoagulation for ART |
| Agent: low molecular weight heparin53 |
| Length: for 3 mo post-DVT; for 3 mo post-OHSS symptoms53 |
| Anticoagulation per ASH guidelines in pregnancy53 |
ASH, American Society of Hematology; OHSS, ovarian hyperstimulation syndrome.